[Congressional Record Volume 165, Number 81 (Wednesday, May 15, 2019)]
[Senate]
[Pages S2889-S2890]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

      By Mr. UDALL (for himself and Mr. Wyden):
  S. 1488. A bill to improve the integrity and safety of interstate 
horseracing, and for other purposes; to the Committee on Commerce, 
Science, and Transportation.
  Mr. UDALL. Mr. President, I ask unanimous consent that the text of 
the bill be printed in the Record.
  There being no objection, the text of the bill was ordered to be 
printed in the Record, as follows:

                                S. 1488

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``Racehorse Doping Ban Act of 
     2019''.

     SEC. 2. DEFINITIONS.

       In this Act:
       (1) Interstate off-track wager; horsemen's group; host 
     racing association; off-track betting system.--The terms 
     ``interstate off-track wager'', ``horsemen's group'', ``host 
     racing association'', and ``off-track betting system'' have 
     the meanings given those terms in section 3 of the Interstate 
     Horseracing Act of 1978 (15 U.S.C. 3002).
       (2) Veterinarian-client-patient relationship.--The term 
     ``veterinarian-client-patient relationship'' has the meaning 
     of that term as used in the Principles of Veterinary Medical 
     Ethics of the American Veterinary Medical Association (as in 
     effect on the date of the enactment of this Act).

     SEC. 3. INDEPENDENT ANTI-DOPING ORGANIZATION FOR INTERSTATE 
                   HORSERACING.

       (a) In General.--There shall be an independent anti-doping 
     organization with responsibility for ensuring the integrity 
     and safety of horseraces that are the subject of interstate 
     off-track wagers.

[[Page S2890]]

       (b) Duties.--The duties of the independent anti-doping 
     organization referred to in subsection (a) with respect to 
     horseraces described in that subsection are the following:
       (1) Developing, publishing, and maintaining rules with 
     respect to--
       (A) substances, methods, and treatments that may not be 
     administered to a horse participating in such a horserace;
       (B) substances, methods, and treatments that may be 
     administered to a horse participating in such a horserace in 
     the context of a veterinarian-client-patient relationship; 
     and
       (C) the use of substances, methods, and treatments 
     permitted under subparagraph (B), including rules with 
     respect to the period before a horserace (which may not be 
     less than 24 hours before a horserace) during which a horse 
     may no longer receive such substances, methods, and 
     treatments.
       (2) Implementing programs relating to anti-doping 
     education, research, testing, and adjudication to prevent any 
     horse participating in a horserace described in subsection 
     (a) from racing under the effect of any substance, method, or 
     treatment that could affect the performance of the horse 
     (other than a substance, method, or treatment described in 
     subparagraph (B) of paragraph (1) administered during a time 
     period that is permitted under subparagraph (C) of that 
     paragraph).
       (3) Excluding from participating in any horserace described 
     in subsection (a) any person that the independent anti-doping 
     organization or a State racing commission determines--
       (A) has violated a rule with respect to a substance, 
     method, or treatment that may not be administered to a horse 
     participating in such a horserace under subparagraph (A) of 
     paragraph (1);
       (B) has violated 3 or more times a rule with respect to a 
     substance, method, or treatment permitted under subparagraphs 
     (B) and (C) of that paragraph that has the ability to affect 
     the performance of a horse; or
       (C) is subject to a suspension from horseracing activities 
     by any State racing commission.
       (c) Deadline.--The independent anti-doping organization 
     referred to in subsection (a) shall publish the rules 
     required by subsection (b) not later than one year after the 
     date of the enactment of this Act.
       (d) Suspension of Exclusion Period.--The independent anti-
     doping organization referred to in subsection (a) may--
       (1) suspend a period of exclusion from participating in a 
     horserace imposed on a person pursuant to subsection (b)(3) 
     if the person provides substantial assistance to the 
     organization or other persons that results in the discovery 
     of--
       (A) a violation of a rule published under subsection (b) by 
     another person; or
       (B) a violation of Federal or State law by another person; 
     and
       (2) reinstate all or part of a period of exclusion imposed 
     on a person and suspended under paragraph (1) if the person 
     fails to provide substantial assistance described in that 
     paragraph.
       (e) Consultations.--In developing, publishing, and 
     maintaining rules under subsection (b)(1), the independent 
     anti-doping organization referred to in subsection (a) may 
     consult with State racing commissions, host racing 
     associations, horsemen's groups, and other interested 
     persons.
       (f) Transition Rule With Respect to Furosemide.--During the 
     2-year period beginning on the date of the enactment of this 
     Act, the independent anti-doping organization referred to in 
     subsection (a) shall permit the use of furosemide in a horse 
     participating in a horserace described in subsection (a) if--
       (1) the horse is 3 years old or older; and
       (2) the use of furosemide--
       (A) complies with the requirements of the document entitled 
     ``ARCI-011-020 Medications and Prohibited Substances'' 
     published by the Association of Racing Commissioners 
     International, Inc.; and
       (B) is within the context of a veterinarian-client-patient 
     relationship.
       (g) Designation of Organization.--The independent anti-
     doping organization designated pursuant to section 701 of the 
     Office of National Drug Control Policy Reauthorization Act of 
     2006 (21 U.S.C. 2001) shall serve as the independent anti-
     doping organization referred to in subsection (a).

     SEC. 4. CONSENT REQUIRED FOR ACCEPTANCE OF INTERSTATE OFF-
                   TRACK WAGERS.

       (a) In General.--On and after the date of the enactment of 
     this Act, a host racing association may conduct a horserace 
     that is the subject of an interstate off-track wager, and an 
     interstate off-track wager may be accepted by an off-track 
     betting system, only if consent is obtained from the 
     independent anti-doping organization referred to in section 
     3(a).
       (b) Requirement for Agreement.--
       (1) In general.--A host racing association shall obtain the 
     consent required by subsection (a) of the independent anti-
     doping organization referred to in section 3(a) pursuant to 
     an agreement entered into between the association and the 
     organization that specifies the terms and conditions relating 
     to such consent, including--
       (A) compliance with the rules published under section 3(b); 
     and
       (B) payments to the organization to defray the costs of 
     carrying out the duties of the organization under this Act.
       (2) Defrayal of costs.--The independent anti-doping 
     organization referred to in section 3(a) shall ensure that 
     all of the costs incurred by the organization in carrying out 
     the duties of the organization under this Act are defrayed 
     pursuant to agreements entered into under paragraph (1).

                          ____________________